| Followers | 85 |
| Posts | 5834 |
| Boards Moderated | 6 |
| Alias Born | 08/21/2015 |
Wednesday, August 27, 2025 1:10:31 PM
AbbVie Buys Bretisilocin from Gilgamesh in $1.2B Deal to Expand Depression Drug Pipeline–Another Win in the Psychedelic Space?
https://www.geneonline.com/abbvie-acquires-gilgameshs-bretisilocin-for-1-2-billion-boosting-psychiatric-pipeline-and-reshaping-major-depressive-disorder-treatment/
"AbbVie now joins peers like Johnson & Johnson, Compass Pathways, MindMed, and others in investing in next-generation psychiatric therapies. This strategic pivot underscores increased industry confidence in the potential of such compounds to fill gaps left by conventional treatments."
https://www.geneonline.com/abbvie-acquires-gilgameshs-bretisilocin-for-1-2-billion-boosting-psychiatric-pipeline-and-reshaping-major-depressive-disorder-treatment/
"AbbVie now joins peers like Johnson & Johnson, Compass Pathways, MindMed, and others in investing in next-generation psychiatric therapies. This strategic pivot underscores increased industry confidence in the potential of such compounds to fill gaps left by conventional treatments."
Bullish
Recent ABBV News
- Erin Lichy Gets Real About Her Natrelle® Breast Augmentation • PR Newswire (US) • 04/14/2026 12:50:00 PM
- AbbVie ends CollPlant deal and slashes workforce to cut costs • IH Market News • 04/13/2026 02:06:25 PM
- AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026 • PR Newswire (US) • 04/12/2026 11:15:00 AM
- BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year • PR Newswire (US) • 04/08/2026 12:00:00 PM
- Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:05:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:00:15 PM
- /C O R R E C T I O N -- AbbVie/ • PR Newswire (US) • 03/31/2026 02:04:00 PM
- Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® • PR Newswire (US) • 03/31/2026 12:05:00 PM
- AbbVie to Host First-Quarter 2026 Earnings Conference Call • PR Newswire (US) • 03/31/2026 12:00:00 PM
- Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD) • PR Newswire (US) • 03/30/2026 12:00:00 PM
- AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting • PR Newswire (US) • 03/27/2026 02:00:00 PM
- Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC) • PR Newswire (US) • 03/26/2026 08:00:00 AM
- Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco • PR Newswire (US) • 03/26/2026 07:00:00 AM
- AbbVie Named Official Pharmaceutical Partner of Major League Baseball • PR Newswire (US) • 03/24/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/23/2026 09:09:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/23/2026 09:01:40 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/23/2026 08:59:27 PM
- Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions • PR Newswire (US) • 03/19/2026 07:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/09/2026 08:31:02 PM
- AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults • PR Newswire (US) • 03/09/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 10:05:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2026 10:04:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 10:02:27 PM
